OssiMend BA in Posterolateral Instrumented Lumbar Fusion

Part of paid clinical trials in Encinitas, California.

Sponsor
Collagen Matrix
Study ID
NCT04775537
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • OssiMend™ Bioactive Moldable — DEVICE
    Lumbar Spine fusion with OssiMend™ Bioactive Moldable

Study Details

The primary objective of this study is to measure the success rate of lumbar fusion in subjects at 12 months when instrumented lumbar arthrodesis is performed using OssiMend Bioactive Moldable as the bone grafting material

Key Dates

Start date
Jan 21, 2021
Status verified
Jan 2025
Primary completion
Dec 30, 2026
Completion
Jan 30, 2027

Study Design

Enrollment
120 participants (estimated)

Arms

  • Arm: OssiMend™ Bioactive Moldable
    Patients undergoing Lumber Spine Fusion

Primary Outcome Measure

Fusion Success [ Time Frame: 12 months ]

Central Contacts

Locations (4)

FacilityCityStateZIPSite coordinators
San Diego NeurosurgeryEncinitasCalifornia92024
Kevin Yoo
Kevin Yoo, M.D., F.A.A.N.S., F.A.C.S. (PRINCIPAL_INVESTIGATOR)
Hartford HospitalHartfordConnecticut06102
Nabil Matmati
[email protected]
203-939-5362
Pedro Coutinho, MD (PRINCIPAL_INVESTIGATOR)
University Orthopaedic Associates, Division of OrthoNJSomersetNew Jersey08873
Patricia Seuffert
[email protected]
Matthew McDonnell, MD (PRINCIPAL_INVESTIGATOR)
McKenzie-willamette Medical CenterEugeneOregon97401-

Find similar trials in Encinitas, CA

By research site
San Diego Neurosurgery· Encinitas, CAHartford Hospital· Hartford, CTUniversity Orthopaedic Associates, Division of OrthoNJ· Somerset, NJMcKenzie-willamette Medical Center· Eugene, OR

Related Studies